Published February 2020
| Version v1
Journal article
Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions
- 1. Sunnybrook Odette Cancer Centre. Department of Surgery (Canada)
- 2. Sunnybrook Odette Cancer Centre. Department of Medical Physics (Canada)
- 3. Sunnybrook Research Institute. Clinical Research Program (Canada)
Description
Purpose
: Magnetic Occult Lesion Localization Instrument (MOLLI) is a wireless, non-radioactive alternative for non-palpable breast lesion localization. The primary objective of this first-in-human study was to evaluate the clinical feasibility of using MOLLI for intraoperative localization of non-palpable breast lesions.Methods
: Twenty women with non-palpable breast lesions at a single institution received a lumpectomy using the MOLLI guidance system. Patients were co-localized with magnetic and radioactive markers up to 7 days before excision by a dedicated breast radiologist under sonographic guidance. Both markers were localized intraoperatively using dedicated hand-held probes. The primary outcome was successful excision of the magnetic marker, confirmed radiographically and pathologically. Demographic data, margin positivity, and re-excision rates were collected. Surgical oncologists, radiologists, and pathology staff were surveyed for user satisfaction.Results
: Post-radiological analysis: Post-implant mammograms verified that 17/20 markers were placed directly in the lesion center. Radiologists reported that all marker implantations procedures were "easy" or "very easy" following a single training session. Post-surgical analysis: All MOLLI markers were successfully removed with the specimen during surgical excision. In all cases, surgeons ranked the MOLLI guidance system as "very easy" for lesion localization. Pathologic analysis: All patients had negative margins. All anatomic pathology staff ranked the MOLLI system as "very easy" to localize markers.Conclusions
: The MOLLI guidance system is a reliable and accurate method for intraoperative localization of non-palpable breast lesions. Further evaluation of the MOLLI system in studies against current standards of care is required to demonstrate system cost-effectiveness and improved patient-reported outcomes.Additional details
Identifiers
Publishing Information
- Journal Title
- Breast Cancer Research and Treatment
- Journal Volume
- 179
- Journal Issue
- 3
- Journal Page Range
- p. 671-676
- ISSN
- 0167-6806
- CODEN
- BCTRD6
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55060671
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BIOLOGICAL MARKERS; BIOMEDICAL RADIOGRAPHY; CLINICAL TRIALS; EVALUATION; FIDUCIAL MARKERS; GYNECOLOGY; MAMMARY GLANDS; MEDICAL PERSONNEL; MEDICAL RECORDS; PATHOLOGY; PATIENTS; STANDARDS; SURGERY; TRAINING; ULTRASONOGRAPHY; WOMEN
- Descriptors DEC
- ANIMALS; BODY; DIAGNOSTIC TECHNIQUES; EDUCATION; FEMALES; GLANDS; HUMANS; MAMMALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; PERSONNEL; PRIMATES; RADIOLOGY; TESTING; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2019 © The Author(s) 2019